Lee Bink

Lee is a Scientific Leader in the Biopharm Drug Substance Process Development organization at GlaxoSmithKline. He has over 18 years of experience in process development and scale-up, internal and external tech transfers, and has led or supported several Process Performance Qualification campaigns. In addition, he has authored a number of regulatory submissions, several of which involved an assessment and documentation of Established Conditions, per ICHQ12. He is the R&D lead for the Biopharm QbD and Control Strategy team at GSK and has led or contributed to many aspects of the QbD and Acceleration strategy at GSK.


This speaker has made no appearances.